Fewer newborns are being born with cystic fibrosis in Massachusetts, a decrease that researchers attribute to increased preconception and prenatal screening for the genetic disease, according to an article published in the Feb. 28 issue of the New England Journal of Medicine.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.